While plasma proteins can influence the physicochemical properties of nanoparticles, the
adsorption of protein to the surface of nanomaterials can also alter the structure and function of …

Poly (ethylene glycol) helps nanomaterials evade the immune system by modifying the
composition of proteins that are adsorbed on the surface of the materials.

Tissue hypoxia in solid tumors is caused by several pathological changes associated with
tumor growth, including altered microvasculature structure, increased diffusional distances, …

The human arylamine N-acetyltransferases first attracted attention because of their role in
drug metabolism. However, much of the current literature has focused on their role in the …

Arylamine N-acetyltransferase 1 is a phase II metabolizing enzyme that has been associated
with certain breast cancer subtypes. While it has been linked to breast cancer risk because …

Arylamine N-acetyltransferase-1 (NAT1) is an enzyme that catalyzes the biotransformation
of arylamine and hydrazine substrates. It also has a role in the catabolism of the folate …

Many drugs and chemicals found in the environment are either detoxified by N-acetyltransferase
1 (NAT1, EC 2.3.1.5) and eliminated from the body or bioactivated to metabolites that …

Arylamine N-acetyltransferase I (NAT1) is a phase II enzyme that acetylates a wide range of
arylamine and hydrazine substrates. The NAT1 gene is located on chromosome 8 and …

Expression of human arylamine N‐acetyltransferase I ( NAT 1) has been associated with
various cancer subtypes and inhibition of this enzyme with small molecule inhibitors or si RNA …

Arylamine N-acetyltransferase-1 (NAT1) is a polymorphically expressed enzyme that is widely
distributed throughout the body. In the present study, we provide evidence for substrate-…